Kinkeliba (Combretum micranthum)

Kinkeliba (Combretum micranthum) is a West African medicinal plant containing phenolic compounds and flavonoids that provide antioxidant activity. The plant's extracts demonstrate free radical scavenging properties with DPPH IC₅₀ values of 8.02 μg/mL in laboratory studies.

Origin & History

Kinkeliba is derived from the leaves of Combretum micranthum G. Don, a shrub native to West Africa, particularly Guinea, Senegal, and surrounding regions. The leaves are traditionally prepared as hot water infusions or extracted using ethanol solvents, yielding polyphenol-rich extracts containing gallic acid, rutin, catechin, and benzoic acid.

Historical & Cultural Context

In West African traditional medicine, particularly in Senegalese systems, kinkeliba leaf infusions have been used as a popular bush tea for weight loss, digestion, diuresis, mild antibiotic effects, and pain relief. The leaves are considered the most active plant part compared to stems, bark, or roots.

Health Benefits

• Antioxidant support: In vitro studies show strong free radical scavenging activity (DPPH IC₅₀ 8.02 μg/mL) - preliminary evidence only
• Lipid peroxidation protection: Ethanol extracts demonstrated up to 75.1% inhibition in laboratory tests - preliminary evidence only
• Traditional digestive aid: Used historically in West Africa for digestive support - traditional use only, no clinical trials
• Traditional diuretic effects: Employed in Senegalese medicine for fluid balance - traditional use only, no clinical trials
• Traditional antimalarial support: Used for malarial fever in folk medicine - traditional use only, no clinical trials

How It Works

Kinkeliba's phenolic compounds and flavonoids neutralize reactive oxygen species through electron donation and hydrogen atom transfer mechanisms. The plant's ethanol extracts inhibit lipid peroxidation by breaking oxidative chain reactions in cell membranes. Traditional digestive benefits may involve anti-inflammatory pathways, though specific molecular targets require further research.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Combretum micranthum (kinkeliba). Current evidence is limited to in vitro antioxidant assays, animal toxicity studies, and preliminary pharmacological screenings in laboratory models.

Clinical Summary

Current evidence for kinkeliba comes primarily from in vitro laboratory studies rather than human clinical trials. Antioxidant research shows strong free radical scavenging activity with DPPH IC₅₀ of 8.02 μg/mL and up to 75.1% inhibition of lipid peroxidation in ethanol extracts. While traditionally used for digestive support in West African medicine, controlled human studies are lacking. The existing preliminary evidence requires validation through clinical trials to establish therapeutic efficacy and optimal dosing.

Nutritional Profile

{"macronutrients": {"fiber": "Approximately 5-10% by weight, depending on preparation"}, "micronutrients": {"vitamins": {"Vitamin C": "Trace amounts, specific concentration not well-documented"}, "minerals": {"Calcium": "Approximately 50-100 mg per 100g of dried leaves", "Potassium": "Approximately 200-300 mg per 100g of dried leaves", "Magnesium": "Approximately 30-60 mg per 100g of dried leaves"}}, "bioactive_compounds": {"Flavonoids": "Includes catechins and quercetin derivatives, specific concentrations vary", "Tannins": "High concentration, contributing to antioxidant properties"}, "bioavailability_notes": "Bioavailability of minerals may be affected by the presence of tannins, which can bind to minerals and reduce absorption."}

Preparation & Dosage

No clinically studied dosage ranges are available due to absence of human trials. Traditional preparation involves hot water extracts from dried leaves consumed as a beverage, but no standardized doses or polyphenol content specifications have been established through research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea extract, Vitamin C, Quercetin, Grape seed extract, Milk thistle

Safety & Interactions

Safety data for kinkeliba supplementation is limited, with most traditional use appearing well-tolerated when consumed as tea. No specific drug interactions have been documented, though antioxidant compounds may theoretically interact with certain chemotherapy medications. Pregnant and breastfeeding women should avoid kinkeliba due to insufficient safety data. Individuals with existing medical conditions should consult healthcare providers before use, particularly those on blood-thinning medications.